Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0705-2022Class II

Everest MI XT Inner Dilator, Catalog Number 5101-90167

K2M, Inc / initiated 2022-01-13 / Open, Classified / root cause: manufacturing process

K2M, Inc began a recall of Everest MI XT Inner Dilator, Catalog Number 5101-90167 on . FDA classified it as Class II and gives the reason as "Stryker received two (2) complaints for units from specific lots of Inner and Outer Dilators not fitting together properly during a surgical procedure. Some dilators from these lots and from other lots were subsequently...". As of , the recall status on record is Open, Classified, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-0705-2022
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
K2M, Inc
Product
Everest MI XT Inner Dilator, Catalog Number 5101-90167
Product code
KWP Appliance, Fixation, Spinal Interlaminal
Reason for recall
Stryker received two (2) complaints for units from specific lots of Inner and Outer Dilators not fitting together properly during a surgical procedure. Some dilators from these lots and from other lots were subsequently determined to be affected by a manufacturing nonconformance.
Root cause tag
manufacturing process
FDA root cause
Process control
Action
URGENT: MEDICAL DEVICE RECALL notification letters dated 1/13/22 were sent to customers. Hospital Quality or Materials Managers/Inventory Contacts instructions: Actions needed 1. Immediately check your internal inventory to locate the product listed on the attached Business Reply Form and remove them from their point of use. 2. Use the Business Reply Form to reconcile any affected product. Complete the Business Reply Form even if there is no affected product identified. 3. Return the enclosed Business Reply Form by email to [email protected] or fax to 201- 575-4675 to confirm receipt of this notification/document product segregation. Your account s Stryker Spine Sales Representative will arrange for retrieval and removal of any instruments associated with this recall. 4. In the interim, until units can be removed from your facility by Stryker, there are no additional actions that users can and should take once the product has been segregated and removed from point of use. - If you desire additional training associated with these instructions, please contact our Regulatory Compliance team by calling 201.749.8090 or by email at [email protected], or contact your local Sales representative. 5. Maintain awareness of this communication internally until all required actions have been completed within your facility. 6. Inform Stryker if any of the subject devices have been distributed to other organizations. If so, provide contact details so Stryker can inform the recipients appropriately. 7. Under 21 CFR 803, manufacturers are required to report any serious injuries where a product has contributed or may have contributed to the event. Please keep Stryker informed of any adverse events associated with this product by using Stryker s online reporting site: https://www.stryker.com/productexperience. Additionally, adverse reactions or quality problems experienced with the use of this product may also be reported to the FDA's MedWatch Adver
Quantity in commerce
686 Total Devices
Distribution
Worldwide distribution - US Nationwide.
Product codes and lots
GTIN: 10888857261204; Lot Numbers: JUJF KFMV KUPG KYYU MDRB NDMK NDMX NXJK

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-0705-2022
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-0705-2022Class IIOngoingVoluntary: Firm initiated
Z-0706-2022Class IIOngoingVoluntary: Firm initiated